7Baggers
 HC Wainwright Issues Negative Forecast for Lipocine Earnings  Defense World Mon, 17 Nov 2025 07:32:09 GMT
 HC Wainwright Cuts Lipocine (NASDAQ:LPCN) Price Target to $7.00  Defense World Sun, 16 Nov 2025 08:08:32 GMT
 Lipocine stock price target lowered to $7 at H.C. Wainwright on PPD trial timeline  Investing.com Nigeria Fri, 14 Nov 2025 04:32:46 GMT
 LPCN: Analyst Lowers Price Target While Maintaining Buy Rating |  GuruFocus Thu, 13 Nov 2025 13:54:16 GMT
 Lipocine’s Rising R&D Costs Mark A Tough Quarter For Earnings  Finimize Fri, 07 Nov 2025 23:45:31 GMT
 lipocine: q3 earnings snapshot  CT Insider Fri, 07 Nov 2025 10:01:15 GMT
 lipocine inc. reports q3 2025 financial results  TipRanks Fri, 07 Nov 2025 05:28:28 GMT
 Lipocine (LPCN) Reports Q3 Loss, Tops Revenue Estimates  sharewise.com Fri, 07 Nov 2025 04:33:33 GMT
 lipocine reports q3 eps (59c) vs. (44c) last year  TipRanks Fri, 07 Nov 2025 02:53:40 GMT
 lipocine’s rising r&d costs mark a tough quarter for earnings  Finimize Thu, 06 Nov 2025 21:13:08 GMT
 Lipocine Inc. SEC 10-Q Report  TradingView Thu, 06 Nov 2025 14:43:00 GMT
 Biopharma firm Lipocine's Q3 net loss widens  TradingView Thu, 06 Nov 2025 13:08:37 GMT
 Lipocine (LPCN) Reports Q3 Loss, Tops Revenue Estimates  Yahoo Finance Thu, 06 Nov 2025 08:00:00 GMT
 Lipocine Inc. Reports Q3 2025 Financial Results  TipRanks Thu, 06 Nov 2025 08:00:00 GMT
 Lipocine reports Q3 EPS (59c) vs. (44c) last year  TipRanks Thu, 06 Nov 2025 08:00:00 GMT
 Lipocine: Q3 Earnings Snapshot  San Francisco Chronicle Thu, 06 Nov 2025 08:00:00 GMT
 Lipocine, Inc. Hits 52-Week Low at $2.52 Amidst Declining Sales  Markets Mojo Thu, 06 Nov 2025 04:39:01 GMT
 lipocine presents lpcn 2401 clinical data at obesityweek®  Lelezard Wed, 05 Nov 2025 03:59:32 GMT
 Lipocine Presents LPCN 2401 Clinical Data at ObesityWeek®  Nasdaq Tue, 04 Nov 2025 13:00:00 GMT
 Lipocine Presents Promising LPCN 2401 Data at ObesityWeek  TipRanks Tue, 04 Nov 2025 08:00:00 GMT
 Lipocine Inc Presents LPCN 2401 Clinical Data at ObesityWeek®  TradingView Tue, 04 Nov 2025 08:00:00 GMT
 lipocine, inc. stock plummets to new 52-week low of $2.57  Markets Mojo Fri, 31 Oct 2025 22:47:49 GMT

Lipocine Inc
(NASDAQ:LPCN) 

LPCN stock logo

Lipocine Inc., a clinical-stage biopharmaceutical company, focuses on the development of pharmaceutical products for the treatment of metabolic and endocrine disorders. Its primary development programs are based on oral delivery solutions for poorly bioavailable drugs. The company has a portfolio of...

Full Time Employees: 12
Sector: Healthcare
Industry: Biotechnology

Share this website to your friends